Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

PLX Stock: Why Protalix BioTherapeutics Is Plunging 40% Today

By Robert Lakin, InvestorPlace Contributor

An update from Protalix BioTherapeutics shows how a disappointing FDA decision can roil a biotech name like PLX stock.

NVAX Stock: The Big Covid-19 Vaccine News Lifting Novavax Today

By Robert Lakin, InvestorPlace Contributor

NVAX stock looks to gain for a third straight day as Biden eyes using the Novavax Covid-19 shot to help with international aid.

FTCI Stock IPO: What to Know as FTC Solar Preps to Come Public

By Robert Lakin, InvestorPlace Contributor

A seasoned team of solar industry veterans is behind FTC Solar as the panel tracking equipment and software maker has its IPO. FTCI stock will start trading on Wednesday.

NSPR Stock: What You Should Know About InspireMD Today

By Robert Lakin, InvestorPlace Contributor

InspireMD has vastly reduced the number of its shares trading ahead of a likely move to a Nasdaq listed. Conversion of NSPR stock warrants and preferred shares will be more difficult now.

AXSM Stock: The Big FDA News Giving Axsome Therapeutics a Boost

By Robert Lakin, InvestorPlace Contributor

AXSM stock is gaining on Monday after the FDA granted its new drug application priority review. Here's what you should know now.

OCGN Stock: The White House News That Has Ocugen Climbing Today

By Robert Lakin, InvestorPlace Contributor

OCGN stock is gaining on Monday following an announcement that the White House will back India in its Covid-19 fight.

CCIV Stock: Is a Middle East Connection Boosting Churchill Capital Today?

By Robert Lakin, InvestorPlace Contributor

Lucid Motors is poised to benefit big from e-mobility initiatives in Saudi Arabia. Recent developments bode well for the CCIV stock SPAC target.

PLTR Stock: The New Government Deal Helping Palantir Gain Today

By Robert Lakin, InvestorPlace Contributor

PLTR stock looks to continue its gains on Thursday following an announcement that its software is included in yet another U.K. contract.

ARVL, FSR, CCIV, TSLA, ACTC: The Biden Plan That Has EV Stocks on Watch Today

By Robert Lakin, InvestorPlace Contributor

Several top EV stocks like ARVL stock and FSR stock are on watch today, following remarks from President Joe Biden about EV spending.

OCGN Stock: The Huge COVAXIN News Sending Ocugen Climbing Today

By Robert Lakin, InvestorPlace Contributor

OCGN stock is gaining Wednesday morning on news that Bharat Biotech's COVAXIN has an overall 78% efficacy rate. Here's what to know.

Load More